299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01879228 (ClinicalTrials.gov)	June 2013	12/6/2013	Effect of Chronic Incretin-based Therapy in Cystic Fibrosis	A Randomized, Double-blind, Placebo Controlled Study of the Effectiveness of Chronic Incretin-based Therapy on Insulin Secretion in Cystic Fibrosis	Cystic Fibrosis;Pancreatic Insufficiency	Drug: Sitagliptin	University of Pennsylvania	Children's Hospital of Philadelphia	Completed	18 Years	N/A	All	26	N/A	United States
2	NCT01721382 (ClinicalTrials.gov)	November 2012	26/10/2012	Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis	Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis.	Cystic Fibrosis	Drug: Sitagliptin	Nemours Children's Clinic	NULL	Completed	13 Years	20 Years	Both	6	Phase 1	United States
3	NCT01257464 (ClinicalTrials.gov)	September 2010	2/12/2010	Sitagliptin in Cystic Fibrosis-Related Diabetes	The Effects of the DPPIV Inhibitor Sitagliptin in Cystic Fibrosis-related Diabetes	Cystic Fibrosis	Drug: Sitagliptin;Drug: Placebo	University of British Columbia	NULL	Terminated	19 Years	N/A	Both	3	Phase 2	Canada
4	NCT00967798 (ClinicalTrials.gov)	May 2010	27/8/2009	Prevention of Cystic Fibrosis Diabetes	A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes	Cystic Fibrosis;Prediabetes	Drug: Sitagliptin	Emory University	NULL	Terminated	13 Years	N/A	All	33	Phase 3	United States;Canada